Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Glenmark Pharmaceuticals ltd Remuneration Information 2019

Jul 1, 2019

62608_rns_2019-07-01_1ceb19f8-a1d7-480a-9946-d61431056137.pdf

Remuneration Information

Open in viewer

Opens in your device viewer

==> picture [131 x 63] intentionally omitted <==

==> picture [7 x 165] intentionally omitted <==

==> picture [7 x 105] intentionally omitted <==

==> picture [6 x 68] intentionally omitted <==

Glenmark FoundationGlenmark Aquatic Foundation
Trilegal
RsInmillion
NatureofTransaction Yearended
31March 2019
Purchaseofservices
Trilegal 24.59
ExpenditureincurredforCSRactivitiesto
Glenmark Foundation 141.76
Glen mark Aquatic Foundation 64.00
Transactionswithkeymanagementpersonnel
Remuneration
-Mr.Glenn Saldanha 157.05
- Mrs. Charylann Pinto 42.92
-MrVSMani 45.6
-MrMurali Neelakantan (Relatedpartyasper companies Act,2013tillMay29, 2018) 43.07
-Mr.Harish Kuber 3.27
- Ms. Ruchita Gandhi (Relatedpartyaspercompanies Act,2013witheffectfromJanuary 1,
2019) 1.66
Sitting fees paidtoNOA-executive Directors 8.3

==> picture [5 x 147] intentionally omitted <==

==> picture [83 x 85] intentionally omitted <==